"HLA Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases.
| Descriptor ID |
D006680
|
| MeSH Number(s) |
D23.050.301.500.450 D23.050.705.552.450
|
| Concept/Terms |
HLA Antigens- HLA Antigens
- Antigens, HLA
- HL-A Antigens
- Antigens, HL-A
- HL A Antigens
- Human Leukocyte Antigens
- Antigens, Human Leukocyte
- Leukocyte Antigens, Human
- Leukocyte Antigens
- Antigens, Leukocyte
|
Below are MeSH descriptors whose meaning is more general than "HLA Antigens".
Below are MeSH descriptors whose meaning is more specific than "HLA Antigens".
This graph shows the total number of publications written about "HLA Antigens" by people in this website by year, and whether "HLA Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 2 | 1 | 3 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 2 | 4 |
| 2006 | 1 | 2 | 3 |
| 2007 | 2 | 1 | 3 |
| 2008 | 2 | 2 | 4 |
| 2009 | 2 | 3 | 5 |
| 2010 | 4 | 3 | 7 |
| 2011 | 3 | 1 | 4 |
| 2012 | 2 | 8 | 10 |
| 2013 | 5 | 5 | 10 |
| 2014 | 3 | 3 | 6 |
| 2015 | 6 | 6 | 12 |
| 2016 | 3 | 6 | 9 |
| 2017 | 7 | 2 | 9 |
| 2018 | 4 | 4 | 8 |
| 2019 | 3 | 3 | 6 |
| 2020 | 2 | 5 | 7 |
| 2021 | 4 | 4 | 8 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 4 | 4 |
| 2024 | 0 | 5 | 5 |
| 2025 | 3 | 2 | 5 |
| 2026 | 3 | 2 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "HLA Antigens" by people in Profiles.
-
Long-Term Outcomes of Renal Transplant Allografts With De Novo DSA in the Setting of Stable Function. Clin Transplant. 2026 May; 40(5):e70576.
-
Population-scale sequencing resolves determinants of persistent EBV DNA. Nature. 2026 02; 650(8102):664-672.
-
Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes. J Clin Endocrinol Metab. 2026 Jan 21; 111(2):e493-e499.
-
Germline HLA heterozygosity is associated with decreased lung cancer risk. HGG Adv. 2026 Apr 09; 7(2):100567.
-
Potential synergistic role of pre-formed GSTT1 antibodies and de novo HLA antibodies in a heart-transplant recipient diagnosed with AMR. Hum Immunol. 2026 Feb; 87(2):111648.
-
HLA loci heterozygosity modulates genetic risk in idiopathic inflammatory myopathies. Ann Rheum Dis. 2025 Oct; 84(10):1696-1705.
-
Risk factors for acute rejection in pediatric kidney transplantation. Transpl Immunol. 2025 Sep; 92:102273.
-
Virtual crossmatching: Principles, practices, and the path forward-An American Society for Histocompatibility and Immunogenetics/College of American Pathologists collaborative. Am J Transplant. 2025 Oct; 25(10):2048-2056.
-
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT. Blood Adv. 2025 May 13; 9(9):2356-2365.
-
Type 1 Diabetes Genetic Risk Scores: History, Application and Future Directions. Curr Diab Rep. 2025 Feb 08; 25(1):22.